Thermo Fisher Scientific Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.23B | $2.02B | $1.98B | $1.89B | $1.27B | $1.18B | $1.33B | $1.04B |
| Depreciation & Amortization | $2.03B | $1.76B | $1.69B | $1.68B | $999.9M | $983.7M | $859.6M | $739.7M |
| Depreciation | $439.0M | $380.0M | $373.0M | $353.1M | $236.8M | $236.1M | $211.7M | $185.0M |
| Amortization | $1.59B | $1.38B | $1.31B | $1.33B | $763.1M | $747.6M | $647.9M | $554.7M |
| Stock-Based Compensation | $159.0M | $133.0M | $125.0M | $117.1M | $90.9M | $78.2M | $80.0M | $81.6M |
| Net Cash from Operating Activities | $4.01B | $3.26B | $2.94B | $2.62B | $2.01B | $2.04B | $1.69B | $1.50B |
| Investing Activities | ||||||||
| Capital Expenditures | $508.0M | $444.0M | $423.0M | $427.6M | $282.4M | $315.1M | $260.9M | $245.4M |
| Business Acquisitions | $7.23B | $5.18B | $695.0M | $13.06B | $11.4M | $1.08B | $5.69B | $606.2M |
| Net Cash from Investing Activities | $-7.73B | $-5.52B | $-1.09B | $-11.78B | $-263.3M | $-1.37B | $-5.14B | $-858.9M |
| Financing Activities | ||||||||
| Dividends Paid | $237.0M | $238.0M | $241.0M | $234.8M | $216.2M | $142.2M | $0 | — |
| Stock Repurchases | $750.0M | $1.25B | $500.0M | $0 | $89.8M | $1.15B | $1.34B | $1.01B |
| Net Cash from Financing Activities | $3.85B | $2.76B | $-2.62B | — | — | — | — | $-1.30B |
| Net Change in Cash | $550.0M | $334.1M | $-891.4M | $-4.48B | $5.02B | $-210.7M | $99.2M | $-647.0M |
| Free Cash Flow | $3.50B | $2.81B | $2.52B | $2.19B | $1.73B | $1.72B | $1.43B | $1.25B |